PHILADELPHIA — L. Scott Levin, MD, FACS, was recently elected to the American College of Surgeons’ (ACS) Board of Regents. Board-certified in plastic and reconstructive surgery, Levin is the chairman of Orthopaedic Surgery at the Perelman School of Medicine at the University of Pennsylvania, director of the Penn Hand Transplant Program, professor of Surgery (Division of Plastic Surgery), and the Paul B. Magnuson Professor of Bone and Joint Surgery. In his role as an ACS Regent, Levin will work closely with other members of the College’s Board of Regents to assist in formulating policy on research, health care delivery, and continued education for surgeons. The Board’s diversity and the variety of experiences and interests among its members enable the Regents to represent views related to myriad issues in contemporary surgery.

The 22 members of the ACS’s Board of Regents serve three year terms and are elected by the Nominating Committee of the Board of Governors (NCBG). Nominees are loyal members of the College who have demonstrated outstanding integrity and medical statesmanship along with an unquestioned devotion to the highest principles of surgical practice. They have also demonstrated leadership qualities that might be reflected by service and active participation on ACS committees or in other components of the College.

Levin currently serves as Chairman of the American College of Surgeons’ Advisory Council for Orthopaedic Surgery, and previously served as President of the American Society for Reconstructive Transplantation and the American Society of Reconstructive Microsurgery. An accomplished clinician, Levin’s expertise focuses on surgery of the hand and upper extremity, reconstructive microsurgical techniques for extremity reconstruction, and limb salvage. His research interests focus predominantly on extremity soft tissue reconstruction and Vascularized Composite allotransplantation. In 2011, Levin led a team of Penn Medicine surgeons in the successful completion of the region’s first bilateral hand transplant.

Click here to view the full release.